Disclaimer: Compounded sermorelin is prepared by a licensed 503A compounding pharmacy and has not been reviewed or approved by the FDA. Compounded medications are not the same as commercially available FDA-approved products. This content reflects my perspective as a pharmaceutical executive and founder and is not medical advice. Consult one of our licensed providers for personalized clinical guidance.
Six weeks into his sermorelin protocol, a patient reached out to our team and said he had something to report. He was 51. He had been waking up two or three times a night for as long as he could remember. He had accepted it as something that just happens with age. Six weeks after starting sermorelin, he had slept through the night every night for two weeks. His wife noticed before he did.
That pattern is not unusual. Over two years and hundreds of sermorelin patients in our program, our team has heard some version of it more times than we can count. And the timing, sleep first, before anything else, is not coincidental. It has everything to do with how the molecule works.
What Sermorelin Is: From a Pharmaceutical Standpoint
Sermorelin is a synthetic analog of growth hormone releasing hormone, or GHRH. I want to explain the pharmacology here as someone with a pharmaceutical background, not as clinical guidance.
Sermorelin binds to GHRH receptors on somatotroph cells in the anterior pituitary. Those receptors are G-protein coupled. When GHRH binds, they activate adenylyl cyclase, which raises intracellular cAMP, which triggers GH synthesis and release in a pulsatile pattern. The key word is pulsatile. GH releases in bursts, primarily during deep slow-wave sleep, and the amplitude of those pulses is what determines overall GH activity across a 24-hour period.
Sermorelin amplifies that natural pulsatile release rather than introducing exogenous hormone. Somatostatin, the hypothalamic brake on GH secretion, still applies. The pituitary can still modulate the response. That’s a pharmacologically meaningful distinction from direct HGH therapy, which bypasses the feedback loop entirely.
Research by Corpas and colleagues documented that GH secretion decreases by approximately 14 percent per decade after age 30 (Corpas et al., Endocr Rev 1993, PMID 8491152). By the mid-40s or 50s, GH output may be a fraction of what it was in someone’s 20s. GH’s primary downstream mediator is IGF-1, produced in the liver in response to GH signaling. When GH declines, IGF-1 falls with it, and the anabolic signaling across muscle, bone, and connective tissue weakens.
Sleep Comes First: And Here’s Why
The majority of daily GH secretion happens during slow-wave sleep. When sermorelin begins restoring the amplitude of that nocturnal pulse, what our patients experience first is a qualitative change in sleep. Across hundreds of patients in our program, the pattern is consistent: sleep changes in weeks two to four, before anything visible happens.
That 51-year-old patient’s two weeks of uninterrupted sleep weren’t coincidental. They were what restored somatotroph function looks like in practice.
The relationship between GHRH administration and sleep architecture is documented. Steiger and colleagues showed pulsatile GHRH administration increased slow-wave sleep from 14.0 to 20.2 percent of total sleep time, a 44 percent relative increase, alongside elevated nocturnal GH secretion. That’s the mechanism behind why sleep is the earliest observable signal.
What Comes After: Energy, Recovery, Body Composition
After sleep improves, patients typically describe a baseline shift in energy, not a stimulant effect, but a quieter change where afternoon fatigue arrives later or not at all, and physical recovery tracks more like it used to. The IGF-1 component is relevant here: rising IGF-1 levels support cellular repair and protein synthesis, which determines how quickly someone bounces back from training or physical effort.
Body composition changes take longer. I want to be direct about this because patients often expect them first: visible body composition changes on sermorelin take three to six months. The Rudman 1990 NEJM study, conducted with direct HGH in men over 60, documented measurable lean mass increase and adipose tissue reduction over a six-month window (Rudman et al., NEJM 1990, PMID 2355952). Sermorelin works through the natural pituitary mechanism and won’t produce identical magnitude results, but it operates on the same fundamental axis.
What patients in our program typically report over three to six months: lean muscle holding on better, modest visceral fat reduction, clothes fitting differently, recovery from training improving noticeably. Not dramatic transformation. A meaningful shift that accumulates over time.
What Sermorelin Will Not Do
Sermorelin is not a body recomposition drug. It is not a direct weight loss agent. It will not produce dramatic transformation in isolation. The patients who get the most from it are those who come in with realistic expectations, stay on it long enough for the slower benefits to develop, and treat it as one component of a broader approach to how they take care of themselves.
For the relationship between sermorelin and the testosterone axis, which shares the same nocturnal hormonal window, see Does Sermorelin Increase Testosterone?.
For the clinical dosing detail behind these results, see Sermorelin Dosage for Muscle Growth: A Clinical Guide.
FAQ
When do sermorelin results start showing? Based on what our patient population consistently reports: sleep improvements typically appear in weeks two to four. Energy and recovery improvements follow over the next four to six weeks. Body composition changes develop over three to six months as IGF-1 levels stabilize at a higher baseline. These are observational patterns from our program. Individual results vary, and our clinical team evaluates each patient’s response.
What do patients report before and after sermorelin? Common reports include better sleep quality, faster recovery from exercise, more sustained energy, and gradual body composition improvements over several months. Some patients also report improved hair texture and thickness. Compounded sermorelin has not been reviewed by the FDA.
Is sermorelin the same as HGH? No. Sermorelin works upstream through the GHRH receptor on the pituitary, preserving the body’s natural feedback loop. HGH therapy introduces synthetic growth hormone directly, bypassing that feedback. Different mechanism, different regulatory category, different risk profile.
Does sermorelin help with weight loss? Sermorelin is not a primary weight loss therapy. It can support gradual body composition improvements through the IGF-1 axis. Patients seeking direct weight loss are better served by our dedicated weight loss programs.
What is a realistic sermorelin before and after expectation? Improved sleep, better daily energy, faster recovery, and modest body composition improvements over three to six months. Patients expecting dramatic physical transformation will be disappointed. Patients who want to feel more like a rested, recovered version of themselves consistently report positive outcomes.
References
- Corpas E et al. Human growth hormone and human aging. Endocr Rev. 1993;14(1):20-39. PubMed
- Rudman D et al. Effects of Human Growth Hormone in Men over 60 Years Old. N Engl J Med. 1990;323(1):1-6. PubMed
If you want to talk through whether this is right for you, our providers are available online. Start at www.precisiontelemed.com.
This post reflects my personal perspective as a pharmaceutical executive and founder. It is not medical advice and does not establish a provider-patient relationship. Compounded medications have not been reviewed by the FDA and are not the same as commercially available FDA-approved products. Please consult one of our licensed providers for personalized clinical guidance.
About the Author: JP Rius is the founder of Precision Telemed with a background in pharmaceutical commercial sales, operations, and trade. Over the past two years, his clinical team has served more than 5,000 patients across weight loss, hormone therapy, peptide therapy, and longevity programs. His perspective is shaped by the commercial, regulatory, and operational side of telehealth medicine.